H-1B sponsorship profile: Taro Pharmaceuticals USA, Inc. Across U.S. Department of Labor LCA disclosures, Taro Pharmaceuticals USA, Inc filed 5 Labor Condition Applications covering 5 H-1B worker positions between fiscal year 2023 and fiscal year 2024. The employer’s DOL certification rate sits at 100% (5 certified of 5 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Taro Pharmaceuticals USA, Inc’s H-1B petitions range from $85,000 at the low end to $155,000 at the high end, with a petition-weighted average of $116,182. That range reflects the mix of occupations the company sponsors, led by Senior Quality Analyst, DEA (1 petitions at $103,795 avg), followed by Senior Network Engineer and Senior Manager, Regulatory Affairs. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Taro Pharmaceuticals USA, Inc is headquartered in Hawthorne, NY under NAICS code 325412, and places H-1B workers across 2 states, most heavily in NY, NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Taro Pharmaceuticals USA, Inc ranks. By H-1B petition volume, Taro Pharmaceuticals USA, Inc is #26,547 of 119,880 employers nationally and #2,508 of 14,719 employers headquartered in NY. Both ranks are computed live from the same underlying petition counts, not a separate estimate.